Related references
Note: Only part of the references are listed.Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma
Priya Chudasama et al.
CLINICAL CANCER RESEARCH (2017)
EGFR gene copy number as a predictive/biomarker for patients with non-small-cell lung cancer receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis
Xin Zhang et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2017)
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
Malachi Griffith et al.
NATURE GENETICS (2017)
Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies
Clemens Krepler et al.
CLINICAL CANCER RESEARCH (2016)
High-Throughput Diagnostic Profiling of Clinically Actionable Gene Fusions in Lung Cancer
Nicole Pfarr et al.
GENES CHROMOSOMES & CANCER (2016)
Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling
M. Kordes et al.
LEUKEMIA (2016)
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report
Andrea Casadei Gardini et al.
BMC CANCER (2016)
Modeling Development and Disease with Organoids
Hans Clevers
CELL (2016)
Genotyping of colorectal cancer for cancer precision medicine: Results from the IPH Center for Molecular Pathology
Moritz Jesinghaus et al.
GENES CHROMOSOMES & CANCER (2016)
Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3
Fabrice Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Omics Profiling in Precision Oncology
Kun-Hsing Yu et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience
Maria Schwaederle et al.
MOLECULAR CANCER THERAPEUTICS (2016)
THE TUMOUR TRAIL LEFT IN BLOOD
Kelly Rae Chi
NATURE (2016)
What have we learned from SHIVA?
Christophe Le Tourneau et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Seamless Oncology-Drug Development
Tatiana M. Prowell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer
E. Czink et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2016)
Integration o genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification
Stefan Groeschel et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2016)
Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
Peter Horak et al.
ESMO OPEN (2016)
Evolution of a FLT3-TKD mutated subclone a meningeal relapse in acute promyelocytic leukemia
Tilmann Bochtler et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2016)
A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation
Maria Sereno et al.
ANTI-CANCER DRUGS (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial
Ariel Lopez-Chavez et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
N-of-1 trials in oncology
Laurence Collette et al.
LANCET ONCOLOGY (2015)
Precision medicine: lessons learned from the SHIVA trial
Apostolia M. Tsimberidou et al.
LANCET ONCOLOGY (2015)
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau et al.
LANCET ONCOLOGY (2015)
Patient-centric trials for therapeutic development in precision oncology
Andrew V. Biankin et al.
NATURE (2015)
Time for one-person trials
Nicholas J. Schork
NATURE (2015)
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Giulia Siravegna et al.
NATURE MEDICINE (2015)
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S. Thress et al.
NATURE MEDICINE (2015)
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
David M. Hyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
So rare we need to hunt for them: reframing the ethical debate on incidental findings
Sebastian Schuol et al.
GENOME MEDICINE (2015)
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Peter Eirew et al.
NATURE (2015)
Patient-Derived Xenografts for Individualized Care in Advanced Sarcoma
Justin Stebbing et al.
CANCER (2014)
Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment
Elena Garralda et al.
CLINICAL CANCER RESEARCH (2014)
Physicians' Attitudes About Multiplex Tumor Genomic Testing
Stacy W. Gray et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report
Rehan Akbani et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Sequencing depth and coverage: key considerations in genomic analyses
David Sims et al.
NATURE REVIEWS GENETICS (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Robert C. Green et al.
GENETICS IN MEDICINE (2013)
Designing Transformative Clinical Trials in the Cancer Genome Era
Stefan Sleijfer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
Julia D. Wulfkuhle et al.
CLINICAL CANCER RESEARCH (2012)
A Pilot Characterization of Human Lung NSCLC by Protein Pathway Activation Mapping
Angela Zupa et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer
I. J. Dahabreh et al.
ANNALS OF ONCOLOGY (2011)
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
Sameek Roychowdhury et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Mutations in the DDR2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer
Peter S. Hammerman et al.
CANCER DISCOVERY (2011)
Reverse phase protein microarrays advance to use in clinical trials
Claudius Mueller et al.
MOLECULAR ONCOLOGY (2010)
Translating cancer research into targeted therapeutics
J. S. de Bono et al.
NATURE (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
Jan C. Brase et al.
PROTEOME SCIENCE (2010)
Share Paper
